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Cooperative  interactions  between  thymus-dependent  lymphocytes  (T  cells) and 
antibody-forming cell  precursors  derived  from  the  bone  marrow  (B  cells)  are  im- 
portant for the stimulation  of B  cells  by most soluble antigens  (1-3). This is most 
clearly exemplified  in  the secondary immune response  to  hapten-carrier  complexes 
where T  cells  specific  for  the  carrier  markedly  increase  antibody production by B 
cells specific for the hapten. Alternative mechanisms of secondary B  cell stimulation 
are implied, however, by the finding that hapten on heterologous or poorly immuno- 
genic carriers is also able to stimulate antibody formation (4-6). Recent studies have 
indicated  that such stimulation  can be  the result  of interactions  between  B  and T 
cells  both recognizing haptenic determinants  (6-8).  This demonstration of "hapten 
self-help" questions the notion of direct stimulation of secondary B cells independent 
of T  cell participation. In most studies, except those using very high antigen concen- 
trations  (9) or large polymeric antigens  (10,  11), B  cell stimulation in the absence of 
specific T  cells has not been demonstrable (3, 12). 
Previous  reports  from  this  laboratory  indicated  that  isolated  secondary  B 
cells in splenic  fragment cultures  can be stimulated  to form foci of antibody- 
producing cells  by stimulation  with  hapten  on heterologous carriers  (13,  14). 
This report extends these findings by demonstrating similar results after treat- 
ment of donor cell suspensions before transfer with anti-theta serum and com- 
plement.  Thus, in the apparent complete absence of T  cells,  secondary B  cells 
can be stimulated  by low concentrations of soluble hapten-carrier  conjugates, 
including conjugates in which the carrier is heterologous or nonimmunogenic. 
Materials and Methods 
Antigens.--2,4-dinitrophenyl conjugates of Limulus polyphemus hemocyanin  (DNP-Hy), 
bovine gamma globulin (DNP-BGG),  bovine serum albumin  (DNP-BSA), and poly-L-lysine 
(75,000 tool wt)  (DNP-PLL) were prepared  as previously  described  (5,  13, 14). DNP-BSA 
contained 37 mol of DNP per tool of BSA, DNP-BGG contained 20 tool of DNP per tool of 
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BGG, DNP-PLL contained 34 mol of DNP per tool of PLL, and DNP-Hy contained 10 mol 
of DNP per 100,000  mol of Hy. 
Immunization.--Male  BALB/c mice, to be used as spleen cell donors, were injected intra- 
peritoneally with 0.1 mg of DNP-Hy in complete Freund's adjuvant at 8-12 wk of age. Carrier- 
immunized BALB/c mice were obtained by intraperitoneal injection of 8-wk old males with 
0.1 mg of Hy in complete Freund's adjuvant 4-8 wk before use (14). 
Cell Transfers.--4-7 mo after immunization, mice were killed by cervical dislocation, gpleen 
cell suspensions were prepared in Dulbecco's modified Eagle's medium with a Teflon tissue ho- 
mogenizer.  Viability of  celI  preparations,  as measured  by  trypan  blue  dye  exclusion,  was 
greater than 90%. 
Anti-Theta Serum  Treatment  of Donor  Cells.--Anti-theta  serum was obtained from AKR 
mice injected with thymocytes from  C3H mice according to a modification of the method of 
Reif and Allen (15). The method of treatment of donor spleen cell suspensions was similar to 
that described by Wigzell (16) and is presented in detail in another publication (8). 1 ml of anti- 
theta serum diluted 1:10 in Dulbecco's modified Eagle's medium, 0.15 M  for B-fructose, was 
added per l0  s cells. After 10 rain incubation at 37°C, complement in the form of fresh guinea pig 
serum (GPC)  (0.5 ml/10  s cells) was added and incubation was continued for 30 rain at 37°C. 
After the addition of 5 U/ml of sodium heparin, cells were centrifuged and suspended for in- 
jection.  Control studies  showed  that greater than 90%  of  radioactivity was released from 
BALB/c thymocytes labeled with chromium 51 by this treatment, while 30% of 51Cr was re- 
leased from spleen cells similarly treated (8). 
Spleen  Fragment  C¢dlures.--The  spleen fragment culture system used for these studies, as 
well as the radioimmunoassay of culture fluids,  has been previously reported (5, 13, 14). 
RESULTS 
Table  I  demonstrates  the  effect  of  anti-theta  serum  treatment  on  the  re- 
sponse of transferred secondary spleen cell populations.  As previously reported 
(5) when 2  X  107 spleen cells from an immune donor are transferred to an irradi- 
ated  syngenic  recipient,  fragment  cultures  of  the  recipient's  spleen  respond 
maximally  when  relatively  high  concentration  of  the  homologous  antigen  is 
used  for  in  vitro  stimulation.  This  response  requires  the  presence  of  carrier- 
specific T  cells  (8).  The  effectiveness  of  anti-theta  serum  treatment  is  readily 
apparent  from  the 90%  diminution of  the response  to homologous  complexes. 
That  anti-theta  serum treatment  has no  effect on B  cell  responsiveness per se 
TABLE  I 
Effect of Anti-Theta Serum Treatment  on Response  of Transferred  Secondary  B  Cells in Organ 
Fragment  Cullure 
Treatment of donor cells*  Recipient primed  Maximum  amount of antibody 
with  released per culture per day~ 
None  --  20  4-  4 ng 
Anti-theta serum %  GPC  --  2  4-  1 ng 
None  Hy  48  ±  6 ng 
Anti-theta serum +  GPC  Hy  50  4-  7 ng 
* 2 X  107 spleen cells from DNP-Hy-immunized mice injected into all recipients. 
$ All fragments stimulated with 10  -6 M  DNP determinant concentration on Hy. KLINMAN  AND  DOUGHTY  BRIEF  DEFINITIVE  REPORT  475 
is indicated by the  normal response of anti-theta-treated cells transferred to 
carrier-immunized recipients.  Furthermore,  the  number of  secondary B  cells 
that give rise to clones in fragment cultures derived from carrier-immunized 
recipients is not diminished by anti-theta serum treatment (8). 
Table II shows the response obtained when 1-2  X  10  ~ donor cells with and 
without anti-theta serum treatment were transferred to nonimmune irradiated 
recipients.  Treatment  with  anti-theta  serum  reduced  by  only  31)-40%  the 
number of loci stimulated by the hapten on the homologous carrier and did 
TABLE II 
Effect of A nti-Theta Serum Treatment on the Monofocal Response to Ilapten on tIomologous and 
Heterologous  Carriers 
Treatment of donor cells* 
None 
Anti-theta serum +  GPC 
None 
Anti-theta serum -b GPC 
None 
Anti-theta serum -[- GPC 
None 
Anti-theta serum -[- GPC 
Antigen and DNP-Iysyl 
determinant concentration 
DNP-Hy 10  -7 M 
DNP-Hy 10  -7 M 
DNP-BSA 10  -7 M 
DNP-BSA 10  -7 M 
DNP-BGG 10  -7 M 
DNP-BGG 10  -7 M 
DNP-PLL 104 M 
DNP-PLL 10  -s M 
Foci/lO6-injected  cells producing 
0.7-3 ng of 
antibody 
per day 
0.8 
0.8 
0.7 
0.9 
0.9 
0.8 
0.9 
0.8 
ng of 
±body 
: day 
.7 
.2 
.3 
.2 
.2 
.2 
Total and 
standard 
errors 
1.5  ±  0.1 
1.0  ±  0.3 
1.0  -4- 0.2 
1.1  ±0.3 
1.1  ±0.3 
1.0  ±  0.3 
0.9  +  0.3 
0.8  -4- 0.3 
* 1-2 X 106 spleen cells from DNP-Hy-immunized mice injected per recipient. 
Data represent at least 5 million injected cells for analysis of each antigen in a total of 
three or more separate experiments. The standard  deviation reflects variance in values ob- 
tained from separate experiments. 
not lower at all the frequency of foci stimulated with hapten on heterologous 
carriers. Thus, in spite of the fact that anti-theta treatment reduces by 90 % the 
amount of antibody produced when 2  M  107 cells are transferred to irradiated 
non-carrier-primed recipients, the number of isolated precursor cells responding 
in such  recipients shows  only a  minimal dependence on  theta-sensitive cells 
when the  hapten is presented on the homologous carrier.  No dependence on 
theta-sensitive cells is observed when the hapten is presented on heterologous 
carriers.  Significantly, after anti-theta serum treatment the frequency of loci 
stimulated by the homologous antigen and the amount of antibody produced 
by such foci are similar to that obtained with heterologous carriers, including 
PLL, a poor immunogen in mice (17). 476  KLINMAN  AND  DOUGHTY  BRIEF  DEFINITIVE  REPORT 
DISCUSSION 
The studies  reported  here confirm  the  notion  that  hapten  on heterologous 
carriers  can directly stimulate secondary B  cells without  the participation  of 
T  cells specific for the antigen by demonstrating clonal stimulation with hapten 
on  a  relatively  nonimniunogenic  carrier,  PLL,  and  by  showing  that  clonal 
stimulation by hapten on heterologous carriers is not diminished by the elimi- 
nation of transferred T  cells.  Thus, when spleen cells from a mouse immunized 
to DNP-Hy were transferred to nonimmune irradiated recipients, one fragment 
produced anti-DNP antibody per 106 injected cells after stimulation with DNP- 
BSA,  DNP-BGG,  or  DNP-PLL.  This number was  the  same  even  after  the 
donor cells were  treated  with  anti-theta  serum  and  complement.  Such  treat- 
ment,  however,  could  be  shown  effective in  reducing  by 90%  the  degree  of 
stimulation  obtained  when  large numbers  of cells  (2  X  107) were  transferred 
and did  reduce  the number of isolated  B  cells stimulated  by the homologous 
antigen  to a level equivalent to that achieved by hapten on heterologous car- 
riers.  Thus,  in  the  absence of specific T  cells,  isolated  secondary B  cells  are 
stimulated equally by hapten on homologous, heterologous, or nonimmunogenic 
carriers. 
The  finding  that  after  anti-theta  serum  treatment of spleen cells heterolo- 
gous antigens stimulate as many B  cells as does the homologous antigen indi- 
cates that few, if any, B cells recognize a haptenic determinant in conjunction 
with  determinants  in  its  environment  on  the  carrier used  for immunization. 
Thus, the so called "local environment" (18)  of a hapten appears to play little 
role in B cell recognition. The reduction by anti-theta serum in the frequency of 
B cells stimulated by the homologous antigen does, however, indicate that sus- 
pensions  of  secondary  spleen  cells  contain  occasional  carrier-specific  T  cells 
that can elicit stinmlation of B  cells if both reside in the same fragment. Since 
collaboration with specific T  cells results in an increase in the amount of anti- 
body produced by a stimulated clone (14),  the occurrence of clones producing 
large  amounts  of  antibody  as  a  result  of  stimulation  with  the  homologous 
antigen may also result from the occasional presence of carrier-specific T  cells. 
This T  cell  enhancement of the clonal  response is consistent with  the finding 
that the elimination of T cells results in most foci producing only small amounts 
of antibody regardless of the antigen  used for stimulation. 
Since  anti-theta  serum  did  not  decrease  the  number of foci stimulated  by 
hapten on heterologous carriers, it is unlikely that T  cells recognizing haptenic 
determinants influence  the number of stinmlated loci when small numbers of 
cells (1-2 X  10  '~) are transferred. This would imply that the number of hapten- 
specific T  cells  in  the  spleen  of an  immunized  mouse is  significantly smaller 
than the number of carrier-specific T  cells. 
The data presented in this paper clearly demonstrate that secondary B cells 
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the mechanism of such  stimulation  is not known,  we have previously postu- 
lated that the receptors of secondary B cells, being multivalent, could be cross- 
linked  by multiply substituted  antigens  at low concentrations  and  that such 
receptor  interlinkage  is  necessary  for  stimulation  (14).  The  inability  of  B 
cells from nonimmune mice to be stimulated in  the absence of specific T  cells 
(14)  would  thus  be  consistent  with  the  postulate  that  the  monovalence  of 
primary B  cell receptors limits their interlinkage  (14). 
The amount of antibody produced per stimulated  focus is far lower in  the 
absence of specific T  cells than that obtained by loci in fragments from carrier- 
primed  recipients  (14).  Furthermore,  only  10%  of the precursors stimulated 
in  carrier-primed  recipients  are  stimulated  in  the  absence  of specific T  cells 
(14).  In spite of the fact that only a  fraction of maximum stimulation is ob- 
tained in the absence of carrier specific T  cells, the mechanism of T  cell-inde- 
pendent B  cell stimulation may be important in early defense against viruses 
and  other  agents presenting repeating  determinants,  especially when  antigen 
concentration is low. 
SUMMARY 
Treatment of spleen cell suspensions from immunized mice with  anti-theta 
serum  and  complement  before  transfer  to  nonimmune  irradiated  recipients 
reduced the degree of in vitro stimulation by hapten-homologous carrier com- 
plexes by 90%,  but  did  not  decrease at  all  the number of isolated  precursor 
cells stimulated  by hapten  on heterologous  carriers.  Thus,  secondary B  cells 
can be stimulated by low concentrations of multiply substituted hapten-carrier 
complexes in the apparent complete absence of specific T  cells. 
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